57
Views
1
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study

, , , , , , , , , & show all
Pages 1475-1481 | Received 01 Apr 2009, Accepted 27 May 2009, Published online: 15 Sep 2009

References

  • Chen M G, Prosnitz L R, Gonzalez-Serva A, et al. Results of radiotherapy in control of stage I and II non-Hodgkin lymphoma. Cancer 1979; 43: 1245–1254
  • Reddy S, Saxena V S, Pellettiere E V, et al. Early nodal and extra-nodal non-Hodgkin lymphomas. Cancer 1977; 40: 98–104
  • Connors J M, Klimo P, Fairey R N, et al. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med 1987; 107: 25–30
  • Longo D L, Glatstein E, Duffey P L, et al. Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J Clin Oncol 1989; 7: 1295–1302
  • Tondini C, Zanini M, Lombardi F, et al. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin lymphomas. J Clin Oncol 1993; 11: 720–725
  • Shenkier T N, Voss N, Fairey R, et al. Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency. J Clin Oncol 2002; 20: 197–204
  • Miller T P, Dahlberg S, Cassady J R, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin lymphoma. N Engl J Med 1998; 339: 21–26
  • Freilone R, Botto B, Vitolo U, et al. Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin lymphoma. Ann Oncol 1996; 7: 919–924
  • National Cancer Institute sponsored study of classifications of non-Hodgkin lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112–2135
  • Harris N L, Jaffe E S, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
  • Harris N L, Jaffe E S, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10: 1419–1432
  • Carbone P P, Kaplan H S, Musshoff K, et al. Report of the Committee on Hodgkin disease staging classification. Cancer Res 1971; 31: 1860–1861
  • Cheson B D, Horning S J, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244
  • Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
  • Miller T P, LeBlanc M, Spier C M, et al. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial. Blood 2001; 98: 724a
  • Horning S J, Weller E, Kim K, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 2004; 22: 3032–3038
  • Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 2005; 352: 1197–1205
  • Bernard M, Cartron G, Rachieru P, et al. Long-term outcome of localized high-grade non-Hodgkin lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study. Haematologica 2005; 90: 802–809
  • Bonnet C, Fillet G, Mounier N, et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2007; 25: 787–792
  • Miller T P. The limits of limited stage lymphoma. J Clin Oncol 2004; 22: 2982–2984
  • Istituto Superiore di Sanità, Available from: http://www.iss.it (accessed November 2008)
  • Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235–242
  • Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006; 7: 379–391
  • Persky D O, Unger J M, Spier C M, et al. Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014. J Clin Oncol 2008; 26: 2258–2263

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.